3

PRIMARY DOCUMENT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: June 23, 2017
Period of Report: June 29, 2016
Accession Number: 0001078782-17-000911

View Document ↗ View on SEC.gov ↗